Subscribe to RSS
Please copy the URL and add it into your RSS Feed Reader.
https://www.thieme-connect.de/rss/thieme/en/10.1055-s-00000075.xml
Download PDF
Semin Respir Crit Care Med 2000; 21(2): 0087-0096
DOI: 10.1055/s-2000-9844
DOI: 10.1055/s-2000-9844
Infections in Acute Exacerbation of Chronic Bronchitis: What Are They and How Do We Know?
Further Information
Publication History
Publication Date:
03 March 2004 (online)
ABSTRACT
Acute exacerbations of chronic bronchitis can be due to many factors. The most commonly recognized factor is infection, with bacterial infection being identified in about fifty percent of patients with chronic bronchitis. The causative agent can be detected by several different methods. The most common is sputum examination; however, more invasive techniques have been studied. These include transtracheal aspirates and bronchoscopic samples. The most widely studied bronchoscopic sample has been the protected brush specimen (PBS). Despite the wide array of sampling techniques, the pathogens which have been identified have been relatively consistent. The three most common pathogens have been H. influenzae, S. Pneumoniae, and B. catarrhalis. Other pathogens, including gram negative enteric organisms, are seen in patients with more advanced disease. The information obtained by the diagnostic studies has allowed clinicians to develop treatment strategies for AECB. These diagnostic studies will be needed to help upgrade treatment guidelines as new bacteria and bacterial resistance patterns change.
KEYWORD
Bronchoscopy - BAL (bronchoalveolar lavage) - protected brush - sputum - and transtracheal aspirate
REFERENCES
- 1 Murray P R, Washington J A. Microscopic and bacteriologic analysis of sputum. Mayo Clin Proc . 1975; 50 339-344
- 2 Matsumoto T, Kaku M, Tateda K, Furuya N, Hirakata Y, Yamaguchi K. Detection of antibody-coated bacteria in expectorated sputum for diagnosis of lower respiratory infections. Microbiol Immunol . 1994; 38 287-293
- 3 Wunderink R G, Russell G B, Mezger E, Adams D, Popovich Jr J. The diagnostic utility of the antibody-coated bacteria test in intubated patients. Chest . 1991; 99 84-88
- 4 Cook D J, Mandell L A. Endotracheal aspiration in the diagnosis of ventilator-associated pneumonia. Chest . 2000; 117 195S-197S
- 5 Beghi G, Berni F, Carratu L. Efficacy and tolerability of azithromycin versus amoxicillin/clavulanic acid in acute purulent exacerbation of chronic bronchitis. J Chemother . 1995; 7 146-152
- 6 Zaman M K, Wooten O J, Suprahmanya B, Ankobiah W, Finch P J, Kamholz S L. Rapid noninvasive diagnosis of Pneumocystis carinii from induced liquefied sputum. Ann Intern Med . 1988; 109 7-10
- 7 Fishman J A, Roth R S, Zanzot E, Enos E J, Ferraro M J. Use of induced sputum specimens for microbiologic diagnosis of infections due to organisms other than Pneumocystis carinii J Clin Microbiol . 1994; 32 131-134
- 8 Bigby T B, Margolskee C, Curtis J L. The usefulness of induced sputum in the diagnosis of Pneumocystis carinii pneumonia in patients with acquired immunodeficiency syndrome. Am Rev Respir Dis . 1986; 133 515-518
- 9 Soepandi P, Mangunnegoro H, Yunus F, Gunawan J. The pattern of micro-organisms and the efficacy of new macrolide in acute lower respiratory tract infections. Respirology . 1998; 3 113-117
- 10 Leigh T R, Kirby K, Gazzard B G, Collins J V. Effect of sputum induction on arterial oxygen saturation and spirometry in HIV-infected patients. Eur Respir J . 1994; 7 453-458
- 11 Ramsey B W, Dorkin H L, Eisenberg J D. Efficacy of aerosolized tobramycin in patients with cystic fibrosis. N Engl J Med . 1993; 328 1740-1746
- 12 Regelmann W E, Elliott G R, Warwick W J, Clawson C C. Reduction of sputum Pseudomonas aeruginosa density by antibiotics improves lung function in cystic fibrosis more than do bronchodilators and chest physiotherapy alone. Am Rev Respir Dis . 1990; 141 914-921
- 13 Ramsey B W, Pepe M S, Quan J M. Intermittent administration of inhaled tobramycin in patients with cystic fibrosis. Cystic Fibrosis Inhaled Tobramycin Study Group. N Engl J Med . 1999; 340 23-30
- 14 Kalinske R, Parker R H, Brant D. Diagnostic usefulness and safety of transtracheal aspiration bacteriologic studies. N Engl J Med . 1967; 276 604-608
- 15 Bartlett J G, Rosenblatt S M, Finegold S M. Percutaneous transtracheal aspiration in the diagnosis of anaerobic infection. Ann Intern Med . 1973; 79 535-540
- 16 Davidson M, Tempest B, Palmer D L. Bacteriologic diagnosis of acute pneumonia. Comparison of sputum, transtracheal aspirates, and lung aspirates. JAMA . 1976; 235 158-163
- 17 Bartlett J G. Diagnostic accuracy of transtracheal aspiration bacteriologic studies. Am Rev Respir Dis . 1977; 115 777-782
- 18 Irwin R S, Erickson A D, Pratter M E. Prediction of tracheobronchial colonization in current cigarette smokers with chronic obstructive bronchitis. J Infect Dis . 1982; 145 234-241
- 19 Bjerkestrand G, Digranes A, Schreiner A. Bacteriologic findings in transtracheal aspirates from patients with chronic bronchitis and bronchiectasis. Scand J Resp Dis . 1975; 56 201-207
- 20 Ettinger N A. Invasive diagnostic approaches to pulmonary infiltrates. Semin Respir Infect . 1993; 8 168-176
- 21 Sanchez-Mejorada G, Calva J J, Ponce de Leon S. Usefulness and risks of transtracheal aspiration in the diagnosis of pulmonary infections. Rev Invest Clin . 1991; 43 285-292
- 22 Dorca J. Nonbronchoscopic invasive diagnosis of pneumonia. Clin Pulm Med . 1996; 3 249-257
- 23 Ostergaard L, Andersen P L. Etiology of community-acquired pneumonia. Evaluation by transtracheal aspiration, blood culture, or serology. Chest . 1993; 104 1400-1407
- 24 Alexander W J, Baker G L, Hunker F D. Bacteremia and meningitis following fiberoptic bronchoscopy. Arch Intern Med . 1979; 139 580-583
- 25 Pereira W, Kovnat D M, Khan M A, Iacovino J R, Spivack M L, Snider G L. Fever and pneumonia after flexible fiberoptic bronchoscopy. Am Rev Respir Dis . 1975; 112 59-64
- 26 Sanchez Nieto M J, Torres A, Garcia Cordoba F. Impact of invasive and noninvasive quantitative culture sampling on outcome of ventilator-associated pneumonia: A pilot study. Am J Respir Crit Care Med . 1998; 157 371-376
- 27 el Ebiary M, Torres A, Gonzalez J. Quantitative cultures of endotracheal aspirates for the diagnosis of ventilator-associated pneumonia. Am Rev Respir Dis . 1993; 148 1552-1557
- 28 Jourdain B, Novara A, Joly Guillou L M. Role of quantitative cultures of endotracheal aspirates in the diagnosis of nosocomial pneumonia. Am J Respir Crit Care Med . 1995; 152 241-246
- 29 Avital A, Uwyyed K, Picard E, Godfrey S, Springer C. Sensitivity and specificity of oropharyngeal suction versus bronchoalveolar lavage in identifying respiratory tract pathogens in children with chronic pulmonary infection. Pediatr Pulmonol . 1995; 20 40-43
- 30 Wimberly N, Faling L J, Bartlett J G. A fiberoptic bronchoscopy technique to obtain uncontaminated lower airway secretions for bacterial culture. Am Rev Respir Dis . 1979; 119 337-343
- 31 Meduri G U, Chastre J. The standardization of bronchoscopic techniques for ventilator-associated pneumonia. Chest . 1992; 102 557S-564S
- 32 Baselski V S, el Torky M, Coalson J J, Griffin J P. The standardization of criteria for processing and interpreting laboratory specimens in patients with suspected ventilator-associated pneumonia. Chest . 1992; 102 571S-579S
- 33 Xaubet A, Torres A, Marco F, Puig-De la Bellacasa J, Faus R, Agusti-Vidal A. Pulmonary infiltrates in immunocompromised patients. Diagnostic value of telescoping plugged catheter and bronchoalveolar lavage. Chest . 1989; 95 130-135
- 34 Ferrer M, Torres A, Xaubet A. Diagnostic value of telescoping plugged catheters in HIV-infected patients with pulmonary infiltrates. Chest . 1992; 102 76-83
- 35 Chastre J, Viau F, Brun P. Prospective evaluation of the protected specimen brush for the diagnosis of pulmonary infections in the ventilated patient. Am Rev Respir Dis . 1984; 130 924-929
- 36 Torres A, el Ebiary M, Padro L. Validation of different techniques for the diagnosis of ventilator-associated pneumonia. Comparison with immediate postmortem pulmonary biopsy. Am J Respir Crit Care Med . 1994; 149 324-331
- 37 Middleton R, Broughton W A, Kirkpatrick M B. Comparison of four methods for assessing airway bacteriology in intubated, mechanically ventilated patients. Am J Med Sci . 1992; 304 239-245
- 38 Baughman R P. Protected-specimen brush technique in the diagnosis of ventilator-associated pneumonia. Chest . 2000; 117 203S-206S
- 39 Fagon J Y, Chastre J, Trouillet J L. Characterization of distal bronchial microflora during acute exacerbation of chronic bronchitis. Use of the protected specimen brush technique in 54 mechanically ventilated patients. Am Rev Respir Dis . 1990; 142 1004-1008
- 40 Monso E, Ruiz J, Rosell A. Bacterial infection in chronic obstructive pulmonary disease. A study of stable and exacerbated outpatients using the protected specimen brush. Am J Respir Crit Care Med . 1995; 152 1316-1320
- 41 Monso E, Rosell A, Bonet G. Risk factors for lower airway bacterial colonization in chronic bronchitis. Eur Respir J . 1999; 13 338-342
- 42 Zalacain R, Sobradillo V, Amilibia J. Predisposing factors in bacterial colonization in chronic obstructive lung disease. Eur Respir J . 1999; 13 343-348
- 43 Cabello H, Torres A, Celis R. Bacterial colonization of distal airways in healthy subjects and chronic lung disease: A bronchoscopic study. Eur Respir J . 1997; 10 1137-1144
- 44 Martinez J A, Rodriguez E, Bastida T, Buges J, Torres M. Quantitative study of the bronchial bacterial flora in acute exacerbations of chronic bronchitis. Chest . 1994; 105 976
- 45 Wilson R. Bacterial infection and chronic obstructive pulmonary disease. Eur Respir J . 1999; 13 233-235
- 46 Morris J GJ, Shay D K, Hebden J N. Enterococci resistant to multiple antimicrobial agents, including vancomycin: Establishment of endemicity in a university medical center. Ann Intern Med . 1995; 123 250-259
- 47 Marquette C H, Wallet F, Neviere R. Diagnostic value of direct examination of the protected specimen brush in ventilator-associated pneumonia. Eur Respir J . 1994; 7 105-113
- 48 Baughman R P, Dohn M N, Loudon R G, Frame P T. Bronchoscopy with bronchoalveolar lavage in tuberculosis and fungal infections. Chest . 1991; 99 92-97
- 49 Sternberg R I, Baughman R P, Dohn M N, First M R. Utility of bronchoalveolar lavage in assessing pneumonia in immunosuppressed renal transplant recipients. Am J Med . 1993; 95 358-364
- 50 Thorpe J E, Baughman R P, Frame P T, Wesseler T A, Staneck J L. Bronchoalveolar lavage for diagnosing acute bacterial pneumonia. J Infect Dis . 1987; 155 855-861
- 51 Kahn F W, Jones J M. Diagnosing bacterial respiratory infection by bronchoalveolar lavage. J Infect Dis . 1987; 155 862-869
- 52 Cantral D E, Tape T G, Reed E C, Spurzem J R, Rennard S I, Thompson A B. Quantitative culture of bronchoalveolar lavage fluid for the diagnosis of bacterial pneumonia. Am J Med . 1993; 95 601-607
- 53 Marquette C H, Copin M C, Wallet F. Diagnostic tests for pneumonia in ventilated patients: Prospective evaluation of diagnostic accuracy using histology as a diagnostic gold standard. Am J Respir Crit Care Med . 1995; 151 1878-1888
- 54 Torres A, Martos A, Puig de la Bellacasa J. Specificity of endotracheal aspiration, protected specimen brush, and bronchoalveolar lavage in mechanically ventilated patients. Am Rev Respir Dis . 1993; 147 952-957
- 55 Conrado C E, Rashkin M C, Baughman R P. Pneumonia in immunocompromised and immunocompetent patients requiring mechanical ventilation. J Bronchology . 1999; 6 78-83
- 56 Baughman R P, Dohn M N, Frame P T. The continuing utility of bronchoalveolar lavage to diagnose opportunistic infection in AIDS patients. Am J Med . 1994; 97 515-522
- 57 Rennard S I, Ghafouri M, Thompson A B. Fractional processing of sequential bronchoalveolar lavage to separate bronchial and alveolar samples. Am Rev Respir Dis . 1990; 141 208-217
- 58 Lam S, Leriche J C, Kijek K, Phillips S. Effect of bronchial lavage volume on cellular and protein recovery. Chest . 1985; 88 856-859
- 59 Thompson A B, Bohling T, Payvandi F, Rennard S I. Lower respiratory tract lactoferrin and lysozyme arise primarily in the airways and are elevated in association with chronic bronchitis. J Lab Clin Med . 1990; 115 148-158
- 60 Pina E M, Keeton D A, Baughman R P. Predictive value of IgA and IgG in bronchial samples of patients with lung cancer. Am J Respir Crit Care Med . 1995; 151 A846
- 61 Dohn M N, Baughman R P. Effect of changing instilled volume for bronchoalveolar lavage in patients with interstitial lung disease. Am Rev Respir Dis . 1985; 132 390-392
- 62 Baughman R P, Keeton D A, Perez C, Wilmott R W. Use of bronchoalveolar lavage semiquantitative cultures in cystic fibrosis. Am J Respir Crit Care Med . 1997; 156 286-291
- 63 Armstrong D S, Grimwood K, Carlin J B. Lower airway inflammation in infants and young children with cystic fibrosis. Am J Respir Crit Care Med . 1997; 156 1197-1204
- 64 Konstan M W, Hilliard K A, Norvell T M, Berger M. Bronchoalveolar lavage findings in cystic fibrosis patients with stable, clinically mild lung disease suggest ongoing infection and inflammation. Am J Respir Crit Care Med . 1994; 150 448-454
- 65 Pang J A, Cheng A, Chan H S, Poon D, French G. The bacteriology of bronchiectasis in Hong Kong investigated by protected catheter brush and bronchoalveolar lavage. Am Rev Respir Dis . 1989; 139 14-17
- 66 Nakamura H, Fujishima S, Inoue T. Clinical and immunoregulatory effects of toxithromycin therapy for chronic respiratory tract infection. Eur Resp J . 1999; 13 1371-1379
- 67 Thompson A B, Huerta G, Robbins R A. The bronchitis index. A semiquantitative visual scale for the assessment of airways inflammation. Chest . 1993; 103 1482-1488
- 68 Costabel U, Maier K, Teschler H, Wang Y M. Local immune components in chronic obstructive pulmonary disease. Respiration . 1992; 59(suppl 1) 17-19
- 69 Lusuardi M, Capelli A, Cerutti C G, Spada E L, Donner C F. Airways inflammation in subjects with chronic bronchitis who have never smoked. Thorax . 1994; 49 1211-1216
- 70 Balbi B, Bason C, Balleari E. Increased bronchoalveolar granulocytes and granulocyte/macrophage colony-stimulating factor during exacerbations of chronic bronchitis. Eur Respir J . 1997; 10 846-850
- 71 Adelroth E. How to measure airway inflammation: Bronchoalveolar lavage and airway biopsies. Can Respir J . 1998; 5 (suppl A) 18A-21A
- 72 Demoly P, Simony Lafontaine J, Chanez P. Cell proliferation in the bronchial mucosa of asthmatics and chronic bronchitics. Am J Respir Crit Care Med . 1994; 150 214-217
- 73 Daunt S R, Kleykamp B O, Staneck J, Baughman R P. Comparison of invasive diagnostic techniques in acute exacerbations of chronic bronchitis. Am J Respir Crit Care Med . 1999; 159 A558
- 74 Ball P. Epidemiology and treatment of chronic bronchitis and its exacerbations. Chest . 1995; 108 43S-52S
- 75 Gump D W, Phillips C A, Forsyth B R, McIntosh K, Lamborn K R, Stouch W H. Role of infection in chronic bronchitis. Am Rev Respir Dis . 1976; 113 465-474
- 76 Niederman M S. Introduction to COPD-the role of infection. Chest . 1997; 112 301S-302S
- 77 Tumova B, Heinz F, Syrucek L. Occurrence and aetiology of acute respiratory diseases: Results of a longterm surveillance programme. Acta Virol . 1989; 33 50-62
- 78 Wiselka M J, Kent J, Cookson J B, Nicholson K G. Impact of respiratory virus infection in patients with chronic chest disease. Epidemiol Infect . 1993; 111 337-346
- 79 Ayres J G, Noah N D, Fleming D M. Incidence of episodes of acute asthma and acute bronchitis in general practice 1976-87. Br J Gen Pract . 1993; 43 361-364
- 80 Lamy M E, Puthier-Simon F, Debacker-Williame E. Respiratory viral infections in hospitalized patients with chronic bronchitis. Chest . 1974; 63 336
- 81 McNamara M J, Phillips I A, Williams O B. Viral and Mycoplasma Pneumoniae infections in exacerbations of chronic lung disease. Am Rev Respir Dis . 1969; 100 19
- 82 Beaty C D, Grayston J T, Wang S P. Infections in patients with chronic obstructive pulmonary disease. Am Rev Respir Dis . 1991; 144 1408-1410
- 83 Hagiwara K, Ouchi K, Tashiro N, Azuma M, Kobayashi K. An epidemic of a pertussis-like illness caused by Chlamydia pneumoniae Pediatr Infect Dis J . 1999; 18 271-275
- 84 Anzueto A, Niederman M S, Tillotson G S. Etiology, susceptibility, and treatment of acute bacterial exacerbations of complicated chronic bronchitis in the primary care setting: Ciprofloxacin 750 mg b.i.d. versus clarithromycin 500 mg b.i.d. Bronchitis Study Group. Clin Ther . 1998; 20 885-900
- 85 Smith C B, Kanner R E, Golden C A, Renzetti A D. Haemophilus influenzae and Haemophilus parainfluenzae in chronic obstructive pulmonary disease. Lancet . 1976; 1 1253-1255
- 86 Gump D W, Christmas W A, Forsyth B R, Phillips C A. Serum and secretory antibodies in patients with chronic bronchitis. Arch Intern Med . 1973; 132 847-851
- 87 Glynn A A. Antibodies to Haemophillus influenzae in chronic bronchitis. BMJ . 1959; 2 911-914
- 88 Murphy T F, Sethi S. Bacterial infection in chronic obstructive pulmonary disease. Am Rev Respir Dis . 1992; 146 1067-1083
- 89 Musher D M, Kubitschek K R, Crennan J, Baughn R E. Pneumonia and acute febrile tracheobronchitis due to Haemophilus influenzae Ann Intern Med . 1983; 99 444-450
- 90 Butt H L, Clancy R L, Cripps A W. Bacterial colonisation of the respiratory tract in chronic bronchitis. Aust N Z J Med . 1990; 20 35-38
- 91 Doern G V. Trends in antimicrobial susceptibility of bacterial pathogens of the respiratory tract. Am J Med . 1995; 99 3S-7S
- 92 Doern G V, Jones R N, Pfaller M A, Kugler K. Haemophilus influenzae and Moraxella catarrhalis from patients with community-acquired respiratory tract infections: Antimicrobial susceptibility patterns from the SENTRY antimicrobial Surveillance Program (United States and Canada, 1997). Antimicrob Agents Chemother . 1999; 43 385-389
- 93 Jorgensen J H, Doern G V, Maher L A, Howell A W, Redding J S. Antimicrobial resistance among respiratory isolates of Haemophilus influenzae, Moraxella catarrhalis, and Streptococcus pneumoniae in the United States. Antimicrob Agents Chemother . 1990; 34 2075-2080
- 94 Ball P, Harris J M, Lowson D, Tillotson G, Wilson R. Acute infective exacerbations of chronic bronchitis. QJM . 1995; 88 61-68
- 95 Verghese A, al Samman M, Nabhan D, Naylor A D, Rivera M. Bacterial bronchitis and bronchiectasis in human immunodeficiency virus infection. Arch Intern Med . 1994; 154 2086-2091
- 96 Hirata Dulas A C, Stein D J, Guay D R, Gruninger R P, Peterson P K. A randomized study of ciprofloxacin versus ceftriaxone in the treatment of nursing home-acquired lower respiratory tract infections. J Am Geriatr Soc . 1991; 39 979-985
- 97 Anzueto A, Niederman M S, Tillotson G S. Etiology, susceptibility, and treatment of acute bacterial exacerbations of complicated chronic bronchitis in the primary care setting: Ciprofloxacin 750 mg b.i.d. versus clarithromycin 500 mg b.i.d. Bronchitis Study Group. Clin Ther . 1998; 20 885-900
- 98 Lees A W, McNaught W. Bacteriology of lower-respiratory-tract secretions, sputum, and upper-respiratory-tract secretions in ``normals'' and chronic bronchitis. Lancet . 1959; 1 1112-1115
- 99 Davies B I, Maesen F PV, Teengs J P. The quinolones in chronic bronchitis. Pharm Weekly Sci . 1986; 8 53-59
- 100 Finland M. Recent advances in the epidemiology of pneumococcal infection. Medicine (Baltimore) . 1942; 21 307-344
- 101 Miller D L, Jones R. The bacterial flora of the upper respiratory tract and sputum of working men. J Pathol Bacteriol . 1964; 87 182-186